Investor Lists

Genomics investors in North America

Updated 7 November 2026

Firms observed backing a genomics company in North America in the last two years, wherever the firm is based.

126investors on the list+12 this week
3,426cheques in 12 months+7% against the market
$28Mmedian round they joined+248% against the market median
92%wrote a cheque in 12 months
65%have led a round

The Top 25

Ordered by cheques observed, never by anything anyone paid for

Deploying now (25)

  1. 1Sequoia CapitalDeploying nowVC firm · United States2,099$35Mmedian roundNov 2026last seen
  2. 2New Enterprise AssociatesDeploying nowVC firm · United States1,610$34Mmedian roundOct 2026last seen
  3. 3Alumni VenturesDeploying nowVC firm · United States1,598$12Mmedian roundNov 2026last seen
  4. 4General CatalystDeploying nowVC firm · United States1,387$27Mmedian roundNov 2026last seen
  5. 5AccelDeploying nowVC firm · United States1,341$32Mmedian roundNov 2026last seen
  6. 6Khosla VenturesDeploying nowVC firm · United States1,128$26Mmedian roundNov 2026last seen
  7. 7Founders FundDeploying nowVC firm · United States1,122$15Mmedian roundOct 2026last seen
  8. 8Bessemer Venture PartnersDeploying nowVC firm · United States1,038$30Mmedian roundNov 2026last seen
  9. 9BoxGroupDeploying nowVC firm · United States773$18Mmedian roundNov 2026last seen
  10. 10Norwest Venture PartnersDeploying nowVC firm · United States705$25Mmedian roundOct 2026last seen
  11. 11VenrockDeploying nowVC firm · United States560$36Mmedian roundOct 2026last seen
  12. 12FlybridgeDeploying nowVC firm · United States534$5Mmedian roundSept 2026last seen
  13. 138VCDeploying nowVC firm · United States497$23Mmedian roundOct 2026last seen
  14. 14Lux CapitalDeploying nowVC firm · United States445$30Mmedian roundNov 2026last seen
  15. 15Madrona Venture GroupDeploying nowVC firm · United States435$14Mmedian roundNov 2026last seen
  16. 16DCVCDeploying nowVC firm · United States431$29Mmedian roundNov 2026last seen
  17. 17RA Capital ManagementDeploying nowPrivate equity · United States395$93Mmedian roundNov 2026last seen
  18. 18National Institutes of HealthDeploying nowGovernment · United States388$2.3Mmedian roundOct 2026last seen
  19. 19Temasek HoldingsDeploying nowVC firm · Singapore384$100Mmedian roundOct 2026last seen
  20. 20NeoDeploying nowAccelerator · United States364$5.5Mmedian roundNov 2026last seen
  21. 21ARCH Venture PartnersDeploying nowVC firm · United States337$74Mmedian roundOct 2026last seen
  22. 22Wellington ManagementDeploying nowVC firm · United States297$130Mmedian roundOct 2026last seen
  23. 23Abstract VenturesDeploying nowVC firm · United States295$13Mmedian roundNov 2026last seen
  24. 24Craft VenturesDeploying nowVC firm · United States283$14Mmedian roundOct 2026last seen
  25. 25International Finance CorporationDeploying nowGovernment · United States283$39Mmedian roundOct 2026last seen
101 more on this list

All 126 are in the app, with filters for stage, sector and market. A free account shows 10 per search, Pro up to 1,000.

See the whole list →

Quick answers about genomics investors in North America

Who are the most active genomics investors in North America?

By cheques observed, the most active are Sequoia Capital, New Enterprise Associates, Alumni Ventures, General Catalyst and Accel.

How many genomics investors in North America are there?

126 are on record. 92% made an investment in the last 12 months and 65% have led a round.

Which stages do genomics investors in North America back?

Of the rounds with a named stage in the last 12 months, mostly Series A (26%) and Seed (22%).

How big are the rounds genomics investors in North America join?

The typical (median) round among the leading investors here is $27M.

Which sectors do genomics investors in North America back most?

In the last 12 months, mostly AI, Biotech and Healthcare.

Which genomics investors in North America lead the most rounds?

Accel (103 led), General Catalyst (97 led) and Sequoia Capital (91 led).

Where are genomics investors in North America based?

Most of the leading investors here are based in the United States (24 of the top 25); the rest in Singapore.

What have genomics investors in North America invested in recently?

Recent rounds include LionBio Therapeutics (Pre-seed, Nov 2026, with South Park Commons), Ocient (Series C, Nov 2026, with In-Q-Tel) and Thinking Machines Lab (Other, Nov 2026, with Accel).

Built from the rounds we watched, refreshed every night. How we count · Report a correction